For exploratory studies or established protocols using both peptides, the blend simplifies logistics
Elevations of the intermediate S-Adenosylhomocysteine (SAH) lead to a feed back inhibition of the function of the cycle and also a reduction in the transsulfuration pathway leading to a deficiency in the production of cysteine and glutathione (James)
Monitor your skin's response and adjust accordingly
If prescribed, care continues with personalized dosing, side-effect management, and ongoing support as your body adapts
Cons: Not specifically FDA-approved for weight loss
Author Contact Robert Postlethwaite, MD, University of Texas Southwestern Medical Center Robert.Postlethwaite [at] UTSouthwestern.edu Media Interview Requests To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.